Primary Site >> Biliary tract Cancer

Gene >> TACC3

  • 2014
  • 2015
  • 2016
  • 2018
Ref: Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.
PMID: 24550739
Ref: New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
PMID: 24563076
 Ref: HER2/neu-directed therapy for biliary tract cancer.
PMID: 26022204
 Ref: Oncogenic Gene Fusion FGFR3-TACC3 Is Regulated by Tyrosine Phosphorylation.
PMID: 26869289
 Ref: HSP90 inhibition drives degradation of FGFR2 fusion proteins: implications for treatment of cholangiocarcinoma.
PMID: 30067876